Recursion Enters Into Global Licensing Agreement with Takeda to Develop TAK-733 in Hereditary Cancer Syndrome Read more
Neuraptive Therapeutics Announces FDA has Granted Fast Track Designation to NTX-001 Clinical Development Program for Treatment of Patients with Peripheral Nerve Injuries Read more
Evonik commissions advanced biomaterials production facility for pharmaceutical and medical applications in Birmingham, Alabama Read more